AI assistant
Sending…
KEI Industries Ltd. — Share Issue/Capital Change 2021
Sep 28, 2021
62468_rns_2021-09-28_d2ff108b-bba8-491d-9525-5e04a87c5a25.PDF
Share Issue/Capital Change
Open in viewerOpens in your device viewer
| tails: | ||
|---|---|---|
| a. | Brief Details of options granted; | 10,000 options (Grant IV) |
| b. | Whether the scheme is in terms of SEBI (SBEB) | Yes |
| Regulations, 2014; | ||
| c. | Total Number of shares covered by these options; | 4,000 options exercised equivalent to 4,000 Equity Shares |
| of face value of Z 2/- each. (However, in-principal approval | ||
| taken from Stock Exchange(s) under the KEI Employee | ||
| Stock Option Scheme — 2015 is for 38,00,000 Equity | ||
| Shares of face value of Z 2/- each) | ||
| d. | Pricing Formula; | ? 225/- per Option. |
| e. | Options vested; | 10,000 options |
| f. | Time within which option may be exercised; | 30 days from vesting date. |
| g. | Options exercised; | 4,000 Options |
| h. | Money realized by exercise of options; | ? 9,00,000 /- (Rupees Nine Lakhs Only) |
| i. | The total number of shares arising as a result of exercise | 4,000 Equity Shares of face value of |
| of options; | ? 2/- each | |
| j. | Options lapsed / Not Exercised | 6,000 options |
| k. | Variation of terms of options; | None. |
| I. | Brief details of significant terms; | As per KEI Employees Stock Option Scheme — 2015 |
| m. | Subsequent changes or cancellation or exercise of such | N.A. |
| options; | ||
| n. | Diluted earnings per share pursuant to issue of equity | **?**30.17 (as per Audited Balance Sheet as on 31.03.2021) |
| shares on exercise of options. |
==> picture [81 x 6] intentionally omitted <==
==> picture [422 x 202] intentionally omitted <==
More from KEI Industries Ltd.
Board/Management Information
2026
Jun 1
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
M&A Activity
2026
May 20
Capital/Financing Update
2026
May 20
M&A Activity
2026
May 20
Regulatory Filings
2026
May 18